Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome

Int J Womens Health. 2022 Apr 1:14:467-479. doi: 10.2147/IJWH.S345853. eCollection 2022.

Abstract

Polycystic ovary syndrome (PCOS) is the most common cause of infertility in reproductive-age women. Increased reactive oxygen species levels and decreased antioxidant capacity in PCOS patients can lead to metabolic disorders and damage the ovarian tissues, resulting in the occurrence of related symptoms. Antioxidants have been used in the treatment of PCOS and have yielded satisfactory outcomes due to their ability to counter oxidative stress. Many experiments on PCOS patients have proved that antioxidants can not only improve the ovarian environment, promote follicular maturation, and elevate oocyte quantities but can also regulate lipid and glucose metabolism as well as vascular endothelial cell function in PCOS patients, thereby attenuating adiposity and reducing the occurrence rate of chronic complications to ensure that patients can obtain long-term benefits. This review describes the use of antioxidants in PCOS, which have been used in the treatment.

Keywords: PCOS; antioxidants; oxidative stress; α-lipoic acid.

Publication types

  • Review

Grants and funding

This work was supported by a grant from the National Natural Science Foundation of China (grant No. 81570765), and a “345 Talent Project” of Sheng Jing Hospital of China Medical University.